Dean R Jones1, H Thomas Lee. 1. Department of Anesthesiology, College of Physicians and Surgeons of Columbia University, New York, NY 10032-3784, USA.
Abstract
PURPOSE OF REVIEW: Acute renal failure causes considerable morbidity and mortality in critically ill patients. To date, there are few therapies available to clinicians that alter outcome. This review will focus on clinical and basic science research efforts related to the diagnosis, pathophysiology, prevention, and treatment of acute renal failure. RECENT FINDINGS: The incidence of acute renal failure may be increasing and the mortality rate continues to be significant. The development of sensitive, predictive biomarkers of acute renal failure may help to diagnose the syndrome earlier and allow for meaningful therapeutic intervention. A number of new therapies are in development for acute renal failure. Many show promise in animal models of acute renal failure but prospective studies in humans are lacking. SUMMARY: Despite the present lack of therapies for the treatment and prevention of acute renal failure, there are reasons to be optimistic. Recent research has led to the development of several different strategies that may provide a breakthrough in the treatment of acute renal failure.
PURPOSE OF REVIEW: Acute renal failure causes considerable morbidity and mortality in critically illpatients. To date, there are few therapies available to clinicians that alter outcome. This review will focus on clinical and basic science research efforts related to the diagnosis, pathophysiology, prevention, and treatment of acute renal failure. RECENT FINDINGS: The incidence of acute renal failure may be increasing and the mortality rate continues to be significant. The development of sensitive, predictive biomarkers of acute renal failure may help to diagnose the syndrome earlier and allow for meaningful therapeutic intervention. A number of new therapies are in development for acute renal failure. Many show promise in animal models of acute renal failure but prospective studies in humans are lacking. SUMMARY: Despite the present lack of therapies for the treatment and prevention of acute renal failure, there are reasons to be optimistic. Recent research has led to the development of several different strategies that may provide a breakthrough in the treatment of acute renal failure.
Authors: Minjae Kim; Sang Won Park; Mihwa Kim; Sean W C Chen; William T Gerthoffer; Vivette D D'Agati; H Thomas Lee Journal: Am J Physiol Renal Physiol Date: 2010-05-19
Authors: Petra Szoleczky; Katalin Módis; Nóra Nagy; Zoltán Dóri Tóth; Douglas DeWitt; Csaba Szabó; Domokos Gero Journal: Arch Biochem Biophys Date: 2011-11-11 Impact factor: 4.013
Authors: H Thomas Lee; Sean W C Chen; Thomas C Doetschman; Chuxia Deng; Vivette D D'Agati; Mihwa Kim Journal: Am J Physiol Renal Physiol Date: 2008-04-23
Authors: Sean W C Chen; Minjae Kim; Mihwa Kim; Joseph H Song; Sang Won Park; Dominic Wells; Kevin Brown; Jacqueline de Belleroche; Vivette D D'Agati; H Thomas Lee Journal: Kidney Int Date: 2008-11-19 Impact factor: 10.612
Authors: Minjae Kim; Sean W C Chen; Sang Won Park; Mihwa Kim; Vivette D D'Agati; Jay Yang; H Thomas Lee Journal: Kidney Int Date: 2009-02-04 Impact factor: 10.612
Authors: Sang W Park; Mihwa Kim; Joo Y Kim; Kevin M Brown; Volker H Haase; Vivette D D'Agati; H Thomas Lee Journal: Kidney Int Date: 2012-06-13 Impact factor: 10.612